Spots Global Cancer Trial Database for diffuse adenocarcinoma of the stomach

Every month we try and update this database with for diffuse adenocarcinoma of the stomach cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer	NCT01231399	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri...	fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal...	19 Years -	City of Hope Medical Center
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	NCT01939275	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IA Gastri... Stage IB Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	copper Cu 64-DO... positron emissi... laboratory biom... Computed Tomogr...	18 Years -	City of Hope Medical Center
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	NCT01939275	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IA Gastri... Stage IB Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	copper Cu 64-DO... positron emissi... laboratory biom... Computed Tomogr...	18 Years -	City of Hope Medical Center
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer	NCT01212822	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast...	bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom...	18 Years -	Fox Chase Cancer Center
Irinotecan in Treating Patients With Advanced Cancer of the Stomach	NCT00003137	Esophageal Canc... Gastric Cancer	irinotecan hydr...	18 Years -	Alliance for Clinical Trials in Oncology
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma	NCT00084604	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	irinotecan hydr... bevacizumab cisplatin computed tomogr... laboratory biom...	18 Years -	National Cancer Institute (NCI)
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer	NCT00064259	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	oblimersen sodi... cisplatin fluorouracil	19 Years -	National Cancer Institute (NCI)
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer	NCT01939275	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IA Gastri... Stage IB Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	copper Cu 64-DO... positron emissi... laboratory biom... Computed Tomogr...	18 Years -	City of Hope Medical Center
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer	NCT00103324	Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage III Gastr... Stage IV Gastri...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer	NCT00064259	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	oblimersen sodi... cisplatin fluorouracil	19 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer	NCT00027534	Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ...	TRICOM-CEA(6D)	18 Years -	Duke University
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery	NCT01612546	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	cyclodextrin-ba... Laboratory biom... Pharmacological...	18 Years -	City of Hope Medical Center
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer	NCT02344810	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Gastrointestina... Intestinal Aden... Mixed Adenocarc... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	c-Met inhibitor... placebo oxaliplatin leucovorin calc... fluorouracil pharmacological... laboratory biom...	18 Years -	Eastern Cooperative Oncology Group
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer	NCT01212822	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast...	bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom...	18 Years -	Fox Chase Cancer Center
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery	NCT00991952	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	alvocidib irinotecan hydr... laboratory biom...	18 Years -	National Cancer Institute (NCI)
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer	NCT00103324	Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage III Gastr... Stage IV Gastri...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma	NCT00084604	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	irinotecan hydr... bevacizumab cisplatin computed tomogr... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer	NCT01212822	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast...	bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom...	18 Years -	Fox Chase Cancer Center
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach	NCT00061932	Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri...	bortezomib irinotecan	18 Years -	National Cancer Institute (NCI)
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer	NCT00004099	Gastric Cancer	cisplatin fluorouracil leucovorin calc... neoadjuvant the...	18 Years - 69 Years	European Organisation for Research and Treatment of Cancer - EORTC

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: